📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Retension Pharmaceuticals

1.1 - Company Overview

Retension Pharmaceuticals Logo

Retension Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of healthcare solutions focused on RTN-001, a tissue-targeted PDE5 inhibitor designed to treat hypertension by enhancing nitric oxide action in the central pulmonary vasculature, promoting vasodilation and blood pressure control.

Products and services

  • RTN-001: A tissue-targeted PDE5 inhibitor engineered to treat hypertension by enhancing nitric oxide action in central pulmonary vasculature, promoting vasodilation and precise blood pressure control.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Retension Pharmaceuticals

Respicardia Logo

Respicardia

HQ: United States Website
  • Description: Provider of implantable therapies to improve respiratory rhythm management and cardiovascular health, including the FDA-approved remedÄ“ System for adults with moderate to severe Central Sleep Apnea (CSA) to restore normal breathing during sleep, and the remedÄ“ Patient Pathway offering resources for screening, selection, implant, optimization, and follow-up.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Respicardia company profile →
Hemosphere Logo

Hemosphere

HQ: United States Website
  • Description: Provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hemosphere company profile →
AdvancedCath Logo

AdvancedCath

HQ: United States Website
  • Description: Provider of advanced catheter systems and components, offering design, development and manufacturing services. Delivers high-quality, fast-response, superior solutions and proactive service through a collaborative partnership approach, serving as a fast and flexible development partner.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AdvancedCath company profile →
BioCardia Logo

BioCardia

HQ: United States Website
  • Description: Provider of clinical-stage regenerative cardiology therapies and delivery systems, including CardiAMP autologous bone marrow cell therapy for heart failure, CardiALLO allogeneic mesenchymal stem cell therapy, the Helix system for minimally invasive biologic delivery to the heart, Morph DNA FDA-approved steerable introducer sheaths for cardiac/peripheral procedures, and the AVANCE bi-directional steerable introducer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioCardia company profile →
CardioMind Logo

CardioMind

HQ: United States Website
  • Description: Provider of therapeutic devices for cardiovascular and neurological diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CardioMind company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Retension Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Retension Pharmaceuticals

2.2 - Growth funds investing in similar companies to Retension Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Retension Pharmaceuticals

4.2 - Public trading comparable groups for Retension Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Retension Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Retension Pharmaceuticals

What does Retension Pharmaceuticals do?

Retension Pharmaceuticals is a provider of healthcare solutions focused on RTN-001, a tissue-targeted PDE5 inhibitor designed to treat hypertension by enhancing nitric oxide action in the central pulmonary vasculature, promoting vasodilation and blood pressure control.

Who are Retension Pharmaceuticals's competitors?

Retension Pharmaceuticals's competitors and similar companies include Respicardia, Hemosphere, AdvancedCath, BioCardia, and CardioMind.

Where is Retension Pharmaceuticals headquartered?

Retension Pharmaceuticals is headquartered in United States.

How many employees does Retension Pharmaceuticals have?

Retension Pharmaceuticals has 1,000 employees 🔒.

When was Retension Pharmaceuticals founded?

Retension Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Retension Pharmaceuticals in?

Retension Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Retension Pharmaceuticals

Who are the top strategic acquirers in Retension Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Retension Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Retension Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Retension Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Retension Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Retension Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Retension Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Retension Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Retension Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Retension Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Retension Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Retension Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Retension Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Retension Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Retension Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Retension Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Retension Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Retension Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Retension Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Retension Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Retension Pharmaceuticals